117
Views
1
CrossRef citations to date
0
Altmetric
Original Research

A New Nomogram for Predicting the Postoperative Overall Survival in Patients with Middle-Aged and Elderly Rectal Cancer: A Single Center Retrospective Study in Chinese Population

, ORCID Icon, , , &
Pages 5197-5209 | Published online: 25 May 2022

References

  • Sung H, Ferlay J, Siegel RL. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics? Cancer Commun. 2019;39(1):22. doi:10.1186/s40880-019-0368-6
  • Kim JY, Jang ES, Park SY, et al. Distinct characteristics of colorectal cancer and frequency of right colon cancer in elderly patients of Korea. J Korean Geriatr Soc. 2010;14(3):147. doi:10.4235/jkgs.2010.14.3.147
  • Claassen Y, Vermeer N, Iversen LH, et al. Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison. Br J Cancer. 2018;4(119):517–522. doi:10.1038/s41416-018-0215-6
  • Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. Cancer J Clin. 2016;66(4):337–350. doi:10.3322/caac.21342
  • Austin AM, Kapadia NS, Brooks GA, et al. Comparison of treatment of early-stage breast cancer among Nurses’ Health Study participants and other Medicare beneficiaries. Breast Cancer Res Treat. 2019;174(3):759–767. doi:10.1007/s10549-018-05098-4
  • Lin KY, Tai C, Hsu JC, et al. Overexpression of nuclear protein kinase CK2 alpha catalytic subunit (CK2alpha) as a poor prognosticator in human colorectal cancer. PLoS One. 2011;6(2):e17193. doi:10.1371/journal.pone.0017193
  • Guo Q, Peng YY, Yang H, et al. Prognostic nomogram for postoperative patients with gastroesophageal junction cancer of no distant metastasis. Front Oncol. 2021;11:643261. doi:10.3389/fonc.2021.643261
  • Li Z, Wei J, Gan X, et al. Construction, validation and, visualization of a web-based nomogram for predicting the overall survival and cancer-specific survival of leiomyosarcoma patients with lung metastasis. J Thorac Dis. 2021;13(5):3076–3092. doi:10.21037/jtd-21-598
  • Wang HH, Dai KN, Li AB, Nomogram Predicting A. Overall and cancer-specific survival of patients with primary bone lymphoma: a large population-based study. Biomed Res Int. 2020;2020(4):4235939. doi:10.1155/2020/4235939
  • Battersby NJ, Bouliotis G, Emmertsen KJ, et al. Development and external validation of a nomogram and online tool to predict bowel dysfunction following restorative rectal cancer resection: the POLARS score. Gut. 2018;67(4):688–696. doi:10.1136/gutjnl-2016-312695
  • Lu J, Zheng ZF, Xie JW, et al. Is the 8th edition of the AJCC TNM staging system sufficiently reasonable for all patients with noncardia gastric cancer? A 12,549-patient international database study. Ann Surg Oncol. 2018;25(7):2002–2011. doi:10.1245/s10434-018-6447-0
  • Sl A, Mc A, Gm A, et al. Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer A western monocentric experience. Surg Oncol. 2020;34:223–233.
  • Rutten H, Dulk MD, Lemmens V, et al. Survival of elderly rectal cancer patients not improved: analysis of population based data on the impact of TME surgery. Eur J Cancer. 2007;43(15):2295–2300. doi:10.1016/j.ejca.2007.07.009
  • Liu L, Cao Y, Zhang G, Zhang L, Wang P, Gong J. Long-term outcomes after laparoscopic total mesorectal excision for advanced rectal cancer. South African journal of surgery. Suid Afrikaanse tydskrif vir chirurgie. 2011;49(4):186–189.
  • Wei FZ, Mei SW, Chen JN, et al. Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy. World J Gastroenterol. 2020;26(42):6638–6657. doi:10.3748/wjg.v26.i42.6638
  • Song J, Chen Z, Huang D, et al. Nomogram predicting overall survival of resected locally advanced rectal cancer patients with neoadjuvant chemoradiotherapy. Cancer Manag Res. 2020;12:7375–7382. doi:10.2147/CMAR.S255981
  • Zhang Y, Yan L, Wu Y, et al. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer. BMC Cancer. 2020;20(1):854. doi:10.1186/s12885-020-07359-2
  • Liu LL, Sun JD, Xiang ZL. A nomogram to predict the prognosis of patients with unresected rectal adenocarcinoma undergoing chemoradiotherapy: a population-based study. J Cancer. 2021;12(16):4745–4761. doi:10.7150/jca.61642
  • Phipps A, Baron J, Newcomb P. Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: the Seattle Colon cancer family registry. Cancer. 2011;117(21):4948–4957. doi:10.1002/cncr.26114
  • Zhu Y, Yang SR, Wang PP, et al. Influence of pre-diagnostic cigarette smoking on colorectal cancer survival: overall and by tumour molecular phenotype. Br J Cancer. 2014;110(5):1359–1366. doi:10.1038/bjc.2014.6
  • Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2010;124(10):2406–2415. doi:10.1002/ijc.24191
  • Nickelsen T, Jørgensen T, Kronborg O, et al. Lifestyle and 30-day complications to surgery for colorectal cancer. Acta Oncologica. 2005;44(3):218–223. doi:10.1080/02841860510029707
  • Walter V, Jansen L, Hoffmeister M, et al. Smoking and survival of colorectal cancer patients: systematic review and meta-analysis. Ann Oncol. 2014;25(8):1517–1525. doi:10.1093/annonc/mdu040
  • Deo S, Kumar S, Bhoriwal S, et al. Colorectal cancers in low- and middle-income countries-demographic pattern and clinical profile of 970 patients treated at a tertiary care cancer center in India. JCO Glob Oncol. 2021;7:1110–1115. doi:10.1200/GO.21.00111
  • Jennifer A. Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA. 2008;299(21):2515. doi:10.1001/jama.299.21.2515
  • Tong GX, Chai J, Cheng J, et al. Diagnostic value of rectal bleeding in predicting colorectal cancer: a systematic review. Asian Pac J Cancer Prev. 2014;15(2):1015–1021. doi:10.7314/APJCP.2014.15.2.1015
  • Kim CG, Ahn JB, Jung M, et al. Preoperative serum carcinoembryonic antigen level as a prognostic factor for recurrence and survival after curative resection followed by adjuvant chemotherapy in stage III colon cancer. Ann Surg Oncol. 2017;24(1):227–235. doi:10.1245/s10434-016-5613-5
  • Shin JK, Kim HC, Lee WY, et al. High preoperative serum CA 19-9 levels can predict poor oncologic outcomes in colorectal cancer patients on propensity score analysis. Ann Surg Treat Res. 2019;96(3):107–115. doi:10.4174/astr.2019.96.3.107
  • Morita S, Nomura T, Fukushima Y, Morimoto T, Hiraoka N, Shibata N. Does serum CA19-9 play a practical role in the management of patients with colorectal cancer? Dis Colon Rectum. 2004;47(2):227–232. doi:10.1007/s10350-003-0041-6
  • Katoh H, Yamashita K, Kokuba Y. Diminishing impact of preoperative carcinoembryonic antigen (CEA) in prognosis of Dukes’ C colorectal cancer. Anticancer Res. 2008;28:1933–1941.
  • Wei J, Huang R, Guo S. ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer. Cancer Manag Res. 2018;10:5219–5225. doi:10.2147/CMAR.S179151
  • Chen C, Hsieh M, Hsiao P, et al. A critical reappraisal for the value of tumor size as a prognostic variable in rectal adenocarcinoma. J Cancer. 2017;8(10):1927–1934. doi:10.7150/jca.17930
  • P Kornprat, MJ Pollheimer, RA Lindtner, et al. Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal. Am J Clin Oncol. 2011;34(1):43–49. doi:10.1097/COC.0b013e3181cae8dd
  • Liang Y, Li Q, He D, Chen Y, Li J. Tumor size improves the accuracy of the prognostic prediction of T4a stage colon cancer. Sci Rep. 2021;11(1):16264. doi:10.1038/s41598-021-95828-4
  • Numata M, Yamaguchi T, Kinugasa Y, et al. Index of estimated benefit from lateral lymph node dissection for middle and lower rectal cancer. Anticancer Res. 2017;37(5):2549–2555. doi:10.21873/anticanres.11598
  • Yang J, Chen Q, Li J, et al. Short-term clinical and oncological outcome of prolonging operation interval after neoadjuvant chemoradiotherapy for locally advanced middle and low rectal cancer. Cancer Manag Res. 2020;12:2315–2325. doi:10.2147/CMAR.S245794
  • Ding L, Liu GW, Zhao BC, et al. Artificial intelligence system of faster region-based convolutional neural network surpassing senior radiologists in evaluation of metastatic lymph nodes of rectal cancer. Chin Med J. 2019;132(4):379–387. doi:10.1097/CM9.0000000000000095
  • Benedek Z, Boer ST, Bauer O, et al. An overview of five-year survival in rectal cancer in relation to lymph node status. Chirurgia. 2020;115(6):747–755. doi:10.21614/chirurgia.115.6.747